Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments. (2016)
Attributed to:
The delivery of 150 kDa antibodies to the brain
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11095-016-1872-x
PubMed Identifier: 26903051
Publication URI: http://europepmc.org/abstract/MED/26903051
Type: Journal Article/Review
Volume: 33
Parent Publication: Pharmaceutical research
Issue: 5
ISSN: 0724-8741